Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
Chinese Patent Office
US Army
US Department of Justice
Cipla
Argus Health
QuintilesIMS
Daiichi Sankyo
Merck

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,834,059

« Back to Dashboard

Which drugs does patent 7,834,059 protect, and when does it expire?

Patent 7,834,059 protects NEVANAC and is included in one NDA.

This patent has twenty-three patent family members in twenty-two countries.
Summary for Patent: 7,834,059
Title:Topical nepafenac formulations
Abstract:Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration.
Inventor(s): Wong; Warren (Fort Worth, TX)
Assignee: Alcon, Inc. (Hunenberg, CH)
Application Number:11/292,484
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 7,834,059

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis Pharms Corp NEVANAC nepafenac SUSPENSION/DROPS;OPHTHALMIC 021862-001 Aug 19, 2005 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF TREATING OCULAR INFLAMMATION ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,834,059

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,071,648 Topical nepafenac formulations ➤ Try a Free Trial
8,324,281 Topical nepafenac formulations ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,834,059

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan I358290 ➤ Try a Free Trial
Taiwan 200626132 ➤ Try a Free Trial
Slovenia 1819362 ➤ Try a Free Trial
Russian Federation 2007124638 ➤ Try a Free Trial
Portugal 1819362 ➤ Try a Free Trial
Mexico 2007006558 ➤ Try a Free Trial
South Korea 101289661 ➤ Try a Free Trial
South Korea 20070089687 ➤ Try a Free Trial
Japan 2012041368 ➤ Try a Free Trial
Japan 4968844 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Harvard Business School
US Department of Justice
AstraZeneca
Argus Health
Covington
Express Scripts
Fuji
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot